> Pfizer said it has decided to expand its plant in New Ulm, Germany, to handle manufacturing its worldwide supply of an osteoporosis drug. Story
> P&G, Sanofi Aventis get FDA nod to package once-a-week osteoporosis drug Actonel with six calcium tablets. Release
> EU regulators give Abbott Laboratories expanded approval to market Humira for earlier forms of rheumatoid arthritis and for psoriatic arthritis. Report
> Allon Therapeutics arranged a $6.2 million private placement, the proceeds of which will fund development of two clinical-stage products, an Alzheimer's treatment in Phase I trials, and a drug for cognitive impairment after cardiac bypass surgery, set to start Phase I trials. Story
> Cita Neuro Pharmaceuticals has put off its IPO in favor of negotiations to be acquired by an "international pharmaceutical company," its CEO announced Monday. Release
> Merck today won FDA approval to use its VAQTA hepatitis A vaccine in children as young as 12 months; it previously was approved only in children two years and older. Release
> In face of legal restrictions, some drug makers retire pseudoephedrine-based decongestants; others plan to continue making them. Story
And Finally... Washington, DC-area real estate developers plot research labs, biotech offices, a business incubator, and more adjacent to the FDA's new 3 million sq.ft. campus. Article